Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $107.60 | 13 | 88.6% |
| Food and Beverage | $13.83 | 1 | 11.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $107.60 | 13 | $0 (2017) |
| ABBVIE INC. | $13.83 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.83 | 1 | ABBVIE INC. ($13.83) |
| 2017 | $107.60 | 13 | PFIZER INC. ($107.60) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2017 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $7.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/05/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/23/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/11/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/19/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/29/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/14/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $7.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/14/2017 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $5.30 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/24/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 61 | 4,105 | 5,549 | $613,208 | $135,262 |
| 2022 | 56 | 3,925 | 5,185 | $587,342 | $129,234 |
| 2021 | 52 | 3,841 | 5,088 | $506,753 | $104,276 |
| 2020 | 44 | 3,307 | 4,346 | $422,298 | $133,394 |
All Medicare Procedures & Services
213 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 309 | 536 | $185,456 | $25,592 | 13.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 309 | 309 | $112,167 | $15,061 | 13.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 50 | 50 | $32,600 | $14,067 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 194 | $51,602 | $8,328 | 16.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 108 | 108 | $15,984 | $8,187 | 51.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 61 | 61 | $8,784 | $7,837 | 89.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 396 | 798 | $13,952 | $6,703 | 48.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 338 | 400 | $26,800 | $5,248 | 19.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 133 | 137 | $9,557 | $4,636 | 48.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 91 | 101 | $12,019 | $2,930 | 24.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 61 | 61 | $4,270 | $2,753 | 64.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 234 | 325 | $11,050 | $2,694 | 24.4% |
| 90739 | Hepatitis b vaccine (hepb), cpg-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use | Office | 2023 | 11 | 16 | $5,280 | $2,489 | 47.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 107 | 134 | $9,112 | $2,206 | 24.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 130 | 215 | $8,385 | $2,047 | 24.4% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 16 | 49 | $16,905 | $2,021 | 12.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 59 | 59 | $4,019 | $1,997 | 49.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 38 | 44 | $7,172 | $1,700 | 23.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 81 | 89 | $6,586 | $1,604 | 24.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 30 | $7,164 | $1,531 | 21.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 170 | 196 | $5,096 | $1,240 | 24.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 25 | 25 | $4,150 | $995.89 | 24.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 53 | 64 | $3,904 | $945.92 | 24.2% |
| 86704 | Hepatitis b core antibody measurement | Office | 2023 | 74 | 74 | $3,626 | $873.94 | 24.1% |
| 86706 | Hepatitis b surface antibody measurement | Office | 2023 | 74 | 75 | $3,225 | $789.75 | 24.5% |
About Dr. William Griever, M.D
Dr. William Griever, M.D is a Family Medicine healthcare provider based in Halifax, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316013006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Griever, M.D has received a total of $121.43 in payments from pharmaceutical and medical device companies, with $13.83 received in 2024. These payments were reported across 14 transactions from 2 companies. The most common payment nature is "Education" ($107.60).
As a Medicare-enrolled provider, Griever has provided services to 15,178 Medicare beneficiaries, totaling 20,168 services with total Medicare billing of $502,166. Data is available for 4 years (2020–2023), covering 213 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Halifax, MA
- Active Since 11/27/2006
- Last Updated 03/11/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316013006
Products in Payments
- ELIQUIS (Drug) $94.40
- VRAYLAR (Drug) $13.83
- CHANTIX (Drug) $13.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Halifax
Robert Ettlinger, Md, MD
Family Medicine — Payments: $21,389
Daniel Yutronich, Do, DO
Family Medicine — Payments: $5,934
Dr. Solomon Shapiro, M.d, M.D
Family Medicine — Payments: $19.43
Mr. Francis Mitchell, Md, MD
Family Medicine